Found 94 matching trials
Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China N/A The purpose of the protocol is to achieve an in-depth understanding of the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue PHASE1 NET originate in neuroendocrine cells throughout the body. The goal of this...
Show More Location
Oncology Centre, King Faisal Specialist Hospital & Research Center
Learn More & Join Trial
Resection of the Esophagus and Subsequent Weight Loss N/A The investigators aim to ascertain how food reward signals and eating behav...
Show More Location
Conway Institute, UCD
Learn More & Join Trial
Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients NA The purpose of this study is to investigate if co-treatment of acromegalic ...
Show More Location
Department of Endocrinology, Aarhus University Hospital
Learn More & Join Trial
Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3) EARLY_PHASE1 The goal of this phase 0 proof-of concept study is to measure the therapeut...
Show More Location
Division of Nuclear Medicine, University Hospital Basel
Learn More & Join Trial
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres PHASE2 Neuroendocrine tumors (NETs) and cancers that originate from the gastrointe...
Show More Location
Rocky Mountain Cancer Center
Learn More & Join Trial
Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors PHASE3 The purpose of this study is to verify if adding a locoregional treatment o...
Show More Location
Albano Laziale Ospedale "Regina Apoltolorum"
Learn More & Join Trial
Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment PHASE3 A.Background
More than 90% of patients with multiple endocrine neoplasia t...
Show More Location
Multiple Locations
Learn More & Join Trial
Randomized Phase III of PRRT Versus Interferon PHASE3 The purpose of this study is to assess the benefit of 177Lu-DOTATATE versus...
Show More Location
Jules Bordet Institute
Learn More & Join Trial
Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia N/A Numerous studies describe HRQoL in other cancer types, whereas only sparse ...
Show More Learn More & Join Trial